v3.26.1
Equity-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity of Options Granted Under the Plan
The table below presents the activity of the Company's stock options for the three months ended March 31, 2026:
Number of
stock options		Weighted
average
exercise price per
stock option		Weighted
average
 remaining
contractual
term (in years)		Aggregate
intrinsic value
(in $ millions)
Balance as of December 31, 20259,036,370$8.22 
Exercised (285,000)$6.55 
Balance as of March 31, 20268,751,370$8.27 
Exercisable as of March 31, 20268,751,370$8.27 2.8$— 
Schedule of Activity of RSUs Granted Under the 2022 Plan
The table below presents the activity of the Company’s RSUs for the three months ended March 31, 2026:
Number of RSUs Weighted
average grant
date fair value
Balance as of December 31, 202518,923,511$6.80 
Granted9,761,502$5.44 
Forfeited(105,421)$6.79 
Vested (10,752,591)$6.60 
Balance as of March 31, 202617,827,001$6.18 
Schedule of Equity-based Compensation Expense Recognized in Consolidated Statements of Operations
Total equity-based compensation expense recognized in the Company’s consolidated statements of operations for the three months ended March 31, 2026 and 2025 amount to $17 million and $19 million, respectively ($14 million and $15 million, net of taxes, respectively), and were included as follows:
(in $ millions)Three months ended March 31,
20262025
Cost of revenue (excluding depreciation and amortization)$1 $1 
Sales and marketing 4 5 
Technology and content5 5 
General and administrative7 8 
Total$17 $19